Activating Somatic FGFR2 Mutations in Breast Cancer

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Reintjes, Nadine ^a   Li, Yun ^a   Becker, Alexandra ^a   Rohmann, Edyta ^a   Schmutzler, Rita ^a   Wollnik, Bernd ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 10; FIBROBLAST GROWTH FACTOR RECEPTOR 2; PROTEIN TYROSINE KINASE;

ARTICLE; BREAST CANCER; CONTROLLED STUDY; COPY NUMBER VARIATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FGF10 GENE; FGFR2 GENE; GENE EXPRESSION; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MISSENSE MUTATION; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; MUTANT; NUCLEOTIDE SEQUENCE; PROTEIN DOMAIN; SOMATIC MUTATION; WILD TYPE;

BASE SEQUENCE; BREAST NEOPLASMS; DNA MUTATIONAL ANALYSIS; DNA PRIMERS; FEMALE; FIBROBLAST GROWTH FACTOR 10; GENE DOSAGE; GENETIC ASSOCIATION STUDIES; GERMANY; HEK293 CELLS; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MOLECULAR SEQUENCE DATA; MULTIPLEX POLYMERASE CHAIN REACTION; MUTAGENESIS, SITE-DIRECTED; MUTATION, MISSENSE; PROTEIN-TYROSINE KINASES; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; SIGNAL TRANSDUCTION;

EID: 84875189537     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060264     Document Type: Article

References (45)

1. Hunter DJ, Kraft P, Jacobs KB, Cox DG, Yeager M, et al. (2007) A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet 39: 870-874.
2. Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, et al. (2007) Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447: 1087-1093.
3. Adnane J, Gaudray P, Dionne CA, Crumley G, Jaye M, et al. (1991) BEK and FLG, two receptors to members of the FGF family, are amplified in subsets of human breast cancers. Oncogene 6: 659-663.
4. Jang JH, Shin KH, Park JG, (2001) Mutations in fibroblast growth factor receptor 2 and fibroblast growth factor receptor 3 genes associated with human gastric and colorectal cancers. Cancer Res 61: 3541-3543.
5. Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, et al. (2007) Patterns of somatic mutation in human cancer genomes. Nature 446: 153-158.
6. Stacey SN, Manolescu A, Sulem P, Thorlacius S, Gudjonsson SA, et al. (2008) Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet 40: 703-706.
7. Grose R, Dickson C, (2005) Fibroblast growth factor signaling in tumorigenesis. Cytokine Growth Factor Rev 16: 179-186.
8. Theodorou V, Kimm MA, Boer M, Wessels L, Theelen W, et al. (2007) MMTV insertional mutagenesis identifies genes, gene families and pathways involved in mammary cancer. Nat Genet 39: 759-769.
9. Meyer KB, Maia AT, O'Reilly M, Teschendorff AE, Chin SF, et al. (2008) Allele-specific up-regulation of FGFR2 increases susceptibility to breast cancer. PLoS Biol 6: e108.
10. Ornitz DM, Itoh N, (2001) Fibroblast growth factors. Genome Biol 2: REVIEWS3005.
11. Schlessinger J, (2000) Cell signaling by receptor tyrosine kinases. Cell 103: 211-225.
12. Eswarakumar VP, Lax I, Schlessinger J, (2005) Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev 16: 139-149.
13. Glaser RL, Broman KW, Schulman RL, Eskenazi B, Wyrobek AJ, et al. (2003) The paternal-age effect in Apert syndrome is due, in part, to the increased frequency of mutations in sperm. Am J Hum Genet 73: 939-947.
14. Goriely A, McVean GA, Rojmyr M, Ingemarsson B, Wilkie AO, (2003) Evidence for selective advantage of pathogenic FGFR2 mutations in the male germ line. Science 301: 643-646.
15. Feldman B, Poueymirou W, Papaioannou VE, DeChiara TM, Goldfarb M, (1995) Requirement of FGF-4 for postimplantation mouse development. Science 267: 246-249.
16. Sun X, Meyers EN, Lewandoski M, Martin GR, (1999) Targeted disruption of Fgf8 causes failure of cell migration in the gastrulating mouse embryo. Genes Dev 13: 1834-1846.
17. Colvin JS, Green RP, Schmahl J, Capel B, Ornitz DM, (2001) Male-to-female sex reversal in mice lacking fibroblast growth factor 9. Cell 104: 875-889.
18. McIntosh I, Bellus GA, Jab EW, (2000) The pleiotropic effects of fibroblast growth factor receptors in mammalian development. Cell Struct Funct 25: 85-96.
19. Kato S, Sekine K, (1999) FGF-FGFR signaling in vertebrate organogenesis. Cell Mol Biol (Noisy-le-grand) 45: 631-638.
20. Martin GR, (1998) The roles of FGFs in the early development of vertebrate limbs. Genes Dev 12: 1571-1586.
21. Yu C, Wang F, Kan M, Jin C, Jones RB, et al. (2000) Elevated cholesterol metabolism and bile acid synthesis in mice lacking membrane tyrosine kinase receptor FGFR4. J Biol Chem 275: 15482-15489.
22. Yamashita T, (2005) [Regulatory effect of FGF23 on phosphate and vitamin D metabolism]. Nippon Rinsho 63Suppl 10: 519-522.
23. Jaskoll T, Abichaker G, Witcher D, Sala FG, Bellusci S, et al. (2005) FGF10/FGFR2b signaling plays essential roles during in vivo embryonic submandibular salivary gland morphogenesis. BMC Dev Biol 5: 11.
24. Schlessinger J, Plotnikov AN, Ibrahimi OA, Eliseenkova AV, Yeh BK, et al. (2000) Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. Mol Cell 6: 743-750.
25. Hunter T, (2000) Signaling - 2000 and beyond. Cell 100: 113-127.
26. Miki T, Bottaro DP, Fleming TP, Smith CL, Burgess WH, et al. (1992) Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene. Proc Natl Acad Sci U S A 89: 246-250.
27. Yayon A, Zimmer Y, Shen GH, Avivi A, Yarden Y, et al. (1992) A confined variable region confers ligand specificity on fibroblast growth factor receptors: implications for the origin of the immunoglobulin fold. Embo J 11: 1885-1890.
28. Alarid ET, Rubin JS, Young P, Chedid M, Ron D, et al. (1994) Keratinocyte growth factor functions in epithelial induction during seminal vesicle development. Proc Natl Acad Sci U S A 91: 1074-1078.
29. Gilbert E, Del Gatto F, Champion-Arnaud P, Gesnel MC, Breathnach R, (1993) Control of BEK and K-SAM splice sites in alternative splicing of the fibroblast growth factor receptor 2 pre-mRNA. Mol Cell Biol 13: 5461-5468.
30. Orr-Urtreger A, Bedford MT, Burakova T, Arman E, Zimmer Y, et al. (1993) Developmental localization of the splicing alternatives of fibroblast growth factor receptor-2 (FGFR2). Dev Biol 158: 475-486.
31. Yan G, Fukabori Y, McBride G, Nikolaropolous S, McKeehan WL, (1993) Exon switching and activation of stromal and embryonic fibroblast growth factor (FGF)-FGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy. Mol Cell Biol 13: 4513-4522.
32. Stephens P, Edkins S, Davies H, Greenman C, Cox C, et al. (2005) A screen of the complete protein kinase gene family identifies diverse patterns of somatic mutations in human breast cancer. Nat Genet 37: 590-592.
33. Webster MK, Donoghue DJ, (1997) FGFR activation in skeletal disorders: too much of a good thing. Trends Genet 13: 178-182.
34. Wilkie AO, (1997) Craniosynostosis: genes and mechanisms. Hum Mol Genet 6: 1647-1656.
35. Passos-Bueno MR, Wilcox WR, Jabs EW, Sertie AL, Alonso LG, et al. (1999) Clinical spectrum of fibroblast growth factor receptor mutations. Hum Mutat 14: 115-125.
36. Pollock PM, Gartside MG, Dejeza LC, Powell MA, Mallon MA, et al. (2007) Frequent activating FGFR2 mutations in endometrial carcinomas parallel germline mutations associated with craniosynostosis and skeletal dysplasia syndromes. Oncogene 26: 7158-7162.
37. Iwata T, Chen L, Li C, Ovchinnikov DA, Behringer RR, et al. (2000) A neonatal lethal mutation in FGFR3 uncouples proliferation and differentiation of growth plate chondrocytes in embryos. Hum Mol Genet 9: 1603-1613.
38. Iwata T, Li CL, Deng CX, Francomano CA, (2001) Highly activated Fgfr3 with the K644M mutation causes prolonged survival in severe dwarf mice. Hum Mol Genet 10: 1255-1264.
39. Wilkie AO, (2005) Bad bones, absent smell, selfish testes: the pleiotropic consequences of human FGF receptor mutations. Cytokine Growth Factor Rev 16: 187-203.
40. Tavormina PL, Bellus GA, Webster MK, Bamshad MJ, Fraley AE, et al. (1999) A novel skeletal dysplasia with developmental delay and acanthosis nigricans is caused by a Lys650Met mutation in the fibroblast growth factor receptor 3 gene. Am J Hum Genet 64: 722-731.
41. Webster MK, D'Avis PY, Robertson SC, Donoghue DJ, (1996) Profound ligand-independent kinase activation of fibroblast growth factor receptor 3 by the activation loop mutation responsible for a lethal skeletal dysplasia, thanatophoric dysplasia type II. Mol Cell Biol 16: 4081-4087.
42. Mohammadi M, Schlessinger J, Hubbard SR, (1996) Structure of the FGF receptor tyrosine kinase domain reveals a novel autoinhibitory mechanism. Cell 86: 577-587.
43. Bellus GA, Spector EB, Speiser PW, Weaver CA, Garber AT, et al. (2000) Distinct missense mutations of the FGFR3 lys650 codon modulate receptor kinase activation and the severity of the skeletal dysplasia phenotype. Am J Hum Genet 67: 1411-1421.
44. Goriely A, Wilkie AO Missing heritability: paternal age effect mutations and selfish spermatogonia. Nat Rev Genet 11: 589.
45. Goriely A, Hansen RM, Taylor IB, Olesen IA, Jacobsen GK, et al. (2009) Activating mutations in FGFR3 and HRAS reveal a shared genetic origin for congenital disorders and testicular tumors. Nat Genet 41: 1247-1252.